Vanderbilt and Michigan Join Sigma-Aldrich RNAi Program

    By Jason Derry --

PharmaLive has reported that Vanderbilt-Ingram Cancer Center and the University of Michigan added their names to the list of members currently involved in Sigma-Aldrich's RNAi Partnership Program.  The Program was set up by Sigma-Aldrich to provide members with access to its functional genomics portfolio, which comprises shRNA libraries that target over 30,000 human and mouse genes.  Sigma-Aldrich hopes the Program will enhance RNAi-related research at select academic institutions by offering its members access to background information, search tools, workshops, and techniques relating to RNAi technology.  The Program also provides its members with special pricing on RNAi products.  Other members of the Program include the Cleveland Clinic, Washington University of St. Louis, Princeton University, the Wistar Institute, and Rutgers University.  Those interested in becoming members of the RNAi Partnership Program can check out this link.

Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law, is a molecular biologist and founding author of Patent Docs.